SEC 13F Intelligence

Acadian Asset Management LLC / REGN

Acadian Asset Management LLC’s Regeneron Pharmaceuticals Position

Does Acadian Asset Management LLC own Regeneron Pharmaceuticals (REGN)? Yes — 151.2K shares worth $117M (+0.17% of its 13F portfolio) as of Q1 2026, down from 445.8K shares the prior filed quarter.

Position Value
$117M
Q1 2026
Shares
151.2K
% of Portfolio
+0.17%
Quarters Held
30
currently held

Position History REGN

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $2MQ2 ’19: $622,000Q3 ’19: $256,000Q4 ’19: $724,000Q4 ’19Q1 ’20: $2MQ2 ’20: $50MQ3 ’20: $53MQ4 ’20: $46MQ4 ’20Q1 ’21: $201MQ2 ’21: $247MQ3 ’21: $320MQ4 ’21: $286MQ4 ’21Q1 ’22: $300MQ2 ’22: $212MQ3 ’22: $180MQ4 ’22: $145MQ4 ’22Q1 ’23: $85MQ2 ’23: $59MQ3 ’23: $59MQ4 ’23: $40MQ4 ’23Q1 ’24: $60MQ2 ’24: $77MQ3 ’24: $71MQ4 ’24: $59MQ4 ’24Q1 ’25: $88MQ2 ’25: $244MQ3 ’25: $329MQ4 ’25: $344MQ4 ’25Q1 ’26: $117Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026151.2K$117M+0.17%
Q4 2025445.8K$344M+0.56%
Q3 2025584.5K$329M+0.57%
Q2 2025465.7K$244M+0.50%
Q1 2025139.2K$88M+0.25%
Q4 202482.3K$59M+0.17%
Q3 202467.3K$71M+0.22%
Q2 202472.8K$77M+0.24%
Q1 202462.1K$60M+0.21%
Q4 202345.3K$40M+0.15%
Q3 202371.3K$59M+0.25%
Q2 202382.1K$59M+0.24%
Q1 2023103.0K$85M+0.37%
Q4 2022200.4K$145M+0.71%
Q3 2022261.0K$180M+0.98%
Q2 2022359.4K$212M+1.09%
Q1 2022429.2K$300M+1.24%
Q4 2021452.2K$286M+1.07%
Q3 2021529.5K$320M+1.22%
Q2 2021441.6K$247M+0.93%
Q1 2021425.4K$201M+0.78%
Q4 202094.2K$46M+0.18%
Q3 202095.5K$53M+0.22%
Q2 202080.2K$50M+0.22%
Q1 20203.6K$2M+0.01%
Q4 20191.9K$724,0000.00%
Q3 2019923$256,0000.00%
Q2 20192.0K$622,0000.00%
Q1 20194.8K$2M+0.01%
Q4 201823.6K$9M+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of REGN.